Importantly, this multi‐functional nanocarrier could not only enhance the sensitivity of tumor cells against immunotherapy and reduce tumor immune escape via both Pbrm1/PDL1 gene silencing, but also strengthen the cytotoxic activity of immune cells by blocking PD1/PDL1 axis. This evidence concerns the gene PBRM1 and neoplasm.